The IQVIA team will work with you to understand your business and market access strategy and ensure the reimbursement ‘ask’ aligns with the overall objectives the organization wants to achieve.
We will leverage our core strengths including broad data assets to develop evidence-based and data-driven approaches to give you the critical insights you need to refine your strategy.
With access to our global Centres of Excellence, your studies will use the most innovative methodologies while ensuring robustness of the analyses.
Optimal Reimbursement: IQVIA will directly connect with payers, medical professional and HTA to understand how your therapy is likely to be evaluated and challenges it will face.
Payer Dynamics: With data at its core, IQVIA taps its wealth of data assets to help you understand exactly how payers are evaluating reimbursement therapies, what’s driving their costs and more, to help as you develop market access and communication strategies with payers.
Maximize the Value of Therapy to Payers: IQVIA understands that a positive HTA recommendation is critical in facilitating negotiations and obtaining optimal listing for your product and we will work with you to ensure that your product’s clinical and economic value proposition is maximized.
Disseminate Your Insights: IQVIA will work closely with you to develop content that is scientifically relevant, adds to the overall body of knowledge and is disseminated through the most appropriate channels.
Learn more about how to build a consistent and compelling value story to meet HTA and payer needs.
Published expertise across therapy areas and methodologies.
